NHS-S-S-dPEG®4-Biotin (Cleavable)
CAS: 55750-62-4
Rif. 3D-DPG-6279
50mg | Fuori produzione | ||
500mg | Fuori produzione |
Informazioni sul prodotto
- (2,5-Dioxopyrrolidin-1-yl) 3-(2,5-dioxopyrrol-1-yl)propanoate
- 1-{3-[(2,5-dioxopyrrolidin-1-yl)oxy]-3-oxopropyl}-1H-pyrrole-2,5-dione
- 1H-Pyrrole-1-propanoic acid, 2,5-dihydro-2,5-dioxo-, 2,5-dioxo-1-pyrrolidinyl ester
- 1H-Pyrrole-2,5-dione, 1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]-
- 2,5-Dioxopyrrolidin-1-yl 3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoate
- 2,5-Dioxopyrrolidin-1-yl 3-(2,5-dioxo-2,5-dihydro-lH-pyrrol-1-yl)propanoate
- 3-(2,5-Dioxo-2,5-dihydropyrrol-1-yl)propionic acid 2,5-dioxopyrrolidiny-1-yl ester
- 3-Maleimidopropionic acid N-hydroxysuccinimide ester
- 3-Maleimidopropionic acid N-succinimidyl ester
- 3-Maleimidopropionic acid hydroxysuccinimide ester
- Vedi altri sinonimi
- BMPS (crosslinking agent)
- N-Succinimidyl 3-(N-maleimido)propionate
- Succinimidyl 3-maleimidopropanoate
- Succinimidyl 3-maleimidopropionate
- β-Maleimidopropionic acid N-hydroxysuccinimide ester
NHS-S-S-dPEG®4-Biotin (Cleavable) is a biotinylated dextran sulfate that has been shown to have transfection activity in vitro. The NHS group is attached to the dextran sulfate via a cleavable linker, allowing for the release of the drug from the cell surface. This product has been found to be effective in experiments on cells from bowel diseases and cancer tissues. It has been shown to induce growth factors and inhibit protein synthesis, with potent inducers of cell proliferation.